Corporate Governance

Sound corporate governance principles are the foundation of investor confidence and trust. These principles are critical to maintaining The Medicines Company’s reputation as a company dedicated to excellence in both performance and integrity.

Our commitment to maintaining high business standards and effective governance is essential to all of The Medicines Company's stakeholders, including its employees, customers, partners, investors and the general public. Together, the Board members ensure that The Medicines Company remains a company of integrity and performance.

Code of Conduct & Ethics

In October of 2016, we revised our Global Code of Conduct and Ethics (the “Code”) primarily to reflect our new branding and to update certain section of the Code. More specifically, we: a) incorporated our current purpose statement; b) committed to providing humane care and treatment to research animals; c) revised contact information for reporting adverse events; and d) clarified roles throughout the document.

Courageous communication is a central tenet in applying the Code to our daily business activities. Every employee, officer and director has the responsibility to ask questions, seek guidance, express concerns, and report suspected violations regarding the Code. The Medicines Company maintains an anonymous and confidential 24-hour helpline, 888-475-8376, that provides individuals with the means to raise concerns over any Company activity that may conflict with the law, regulations, Company policies, or the Code.

California Declaration of Compliance

The Medicines Company is committed to establishing and maintaining an effective compliance program that promotes ethical conduct in accordance with the “Compliance Program Guidance for Pharmaceutical Manufacturers,” developed by the United States Department of Health and Human Services Office of Inspector General and which includes policies consistent with industry code. 

Please see the link below for a summary of our compliance program and declaration of compliance with the applicable sections of California’s Health & Safety Code.

EFPIA Transparency Disclosures

As a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA), The Medicines Company is committed to complying with the EFPIA Disclosure Code for payments made to healthcare professionals (HCPs) and Healthcare Organizations (HCOs). Our interactions and engagements with HCPs and HCOs are designed to advance medicine through the exchange of scientific information and to generate insights that all parties can use to improve patient outcomes.

Below are links to information on The Medicines Company’s support for HCPs and HCOs in the countries covered by the EFPIA Disclosure Code and our general methodology for the compilation of such information. The process of compiling and synthesizing such information can be a time-consuming and complex undertaking. In the event that The Medicines Company discovers additional expenditures incurred during the reporting period that should have been included these disclosures, we will update this information accordingly.

Please note that in some countries, privacy law, regulations or codes require consent from HCPs, and in instances where The Medicines Company was unable to gain consent, we have published an aggregated amount per the code requirements.

If you have any questions regarding these reports, please contact

Previous Transparency Action in EFPIA Countries